Chlamydia trachomatis infection of the neovagina in transgender women

Radix, Asa; Harris, Alexander B; Belkind, Uri; Ting, Jess; Goldstein, Zil

doi:10.1093/ofid/ofz470

Cited by 20 publications

(16 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Neovaginal STIs have infrequently been reported in the literature and include HSV and HPV/genital warts in penile-inversion vaginoplasty, C. trachomatis in procedures that involved penile skin and grafts with urethra mucosa or abdominal peritoneal lining (353), and N. gonorrhoeae in both penile-inversion and colovaginoplasty (354)(355)(356)(357)(358)(359). If the vaginoplasty used an intestinal graft, a risk also exists for bowel-related disease (e.g., adenocarcinoma, inflammatory bowel disease, diversion colitis, and polyps) (360)(361)(362).…”

Section: Transgender Womenmentioning

confidence: 99%

Sexually Transmitted Infections Treatment Guidelines, 2021

Workowski¹,

Bachmann²,

Chan³

et al. 2021

MMWR Recomm. Rep.

1,720

2,621

View full text Add to dashboard Cite

These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs. BOX 1. The Five P's approach for health care providers obtaining sexual histories: partners, practices, protection from sexually transmitted infections, past history of sexually transmitted infections, and pregnancy intention Additional information about external condoms is available at https://www.cdc.gov/condomeffectiveness. Internal CondomsCondoms for internal vaginal use, also known as female condoms, are available worldwide (e.g., the FC2 Female Condom, Reddy condom, Cupid female condom, and Woman's condom) (31,32). Use of internal condoms can provide protection from acquisition and transmission of STIs, although data are limited. Internal condoms are more costly compared with external condoms; however, they offer the advantage of being controlled by the receptive partner as an STI and HIV prevention method, and the newer versions might be acceptable to all persons. Although the internal condom also has been used during receptive anal intercourse, efficacy associated with this practice remains unknown (33). Additional information about the internal condom is available at http://www.ashasexualhealth. org/pdfs/Male_and_Female_Condoms.pdf. Cervical DiaphragmsIn observational studies, diaphragm use has been demonstrated to protect against cervical gonorrhea, chlamydia, and trichomoniasis (34). However, a trial examining the effect of a diaphragm plus lubricant on HIV acquisition among women in Africa reported no additional protective effect when compared with the use of male condoms alone. Likewise, no difference by study arm in the rate of acquisition of chlamydia, gonorrhea, or herpes occurred (35,36). Diaphragms should not be relied on as the sole source of protection against HIV and other STIs.

show abstract

Section: Transgender Womenmentioning

confidence: 99%

Sexually Transmitted Infections Treatment Guidelines, 2021

Workowski¹,

Bachmann²,

Chan³

et al. 2021

MMWR Recomm. Rep.

1,720

2,621

View full text Add to dashboard Cite

show abstract

“…Whereas HPV has been associated with penile and scrotal skin, other STIs such as chlamydia or gonorrhoea have a predilection for columnar and transitional epithelium and have been identified in transgender women following GAS with colonic mucosa and integrated urethral or peritoneal grafts. 9,10 Our case report focuses on a transgender woman who underwent vaginoplasty with the penile skin inversion technique and was subsequently diagnosed with neovaginal warts. This case provides evidence for the clinical utility of TCA in a transgender woman with neovaginal warts, and particularly speaks to its functionality when patient-applied treatments are not feasible, or when an operative procedure is not desired or is contraindicated.…”

Section: Discussionmentioning

confidence: 99%

Condylomata acuminata of the neovagina in a transgender woman treated with trichloroacetic acid

Fein

Marbin

2020

Int J STD AIDS

View full text Add to dashboard Cite

Condylomata acuminata (genital warts) have been identified in transgender women after gender affirmation surgery. We describe a case of a 57-year-old transgender woman with biopsy-proven neovaginal condylomata acuminata following gender-affirmation vaginoplasty using the penile skin inversion technique. The patient was successfully treated with trichloroacetic acid. To our knowledge, this is the first case report demonstrating successful treatment of neovaginal condyloma with trichloroacetic acid. We provide a review of the relevant literature and highlight the evidence for the clinical utility of trichloroacetic acid in transgender women with condyloma of the neovagina.

show abstract

“…146 C. trachomatis was detected by urine sampling in two cases, in which condoms were not used during vaginal sex with cis men and treated with 1 g azithromycin. 131 Vaginal perforation was reported in 3 studies. 110,130,135 Two case reports presented this severe complication due to vaginal sexual intercourse.…”

Section: Detection Of Covid-19 In the Male Reproductive Tractmentioning

confidence: 99%

“…18,51,77,104,119,122 3.6.3 | Additional sexual health factors related to activity: STIs after vaginoplasty, severe complications due to intercourse and sexual violence STIs and vaginal candidiasis were outcome measurements that coincided with reports on sexual activity 109,112,120,126,131,146. Case reports and series reported findings of Candida, HSV-1, HPV, and C. trachomatis.…”

mentioning

confidence: 95%

Sexual health after vaginoplasty: A systematic review

et al. 2021

View full text Add to dashboard Cite

Background: Vaginoplasty is a gender-affirming procedure for transgender and gender diverse (TGD) patients who experience gender incongruence. This procedure reduces mental health concerns and enhances patients' quality of life. A systematic review investigating the sexual health outcomes of vaginoplasty has not been performed. Objectives:To investigate sexual health after gender-affirming vaginoplasty for TGD patients.

show abstract

Chlamydia trachomatis infection of the neovagina in transgender women

Cited by 20 publications

References 12 publications

Sexually Transmitted Infections Treatment Guidelines, 2021

Sexually Transmitted Infections Treatment Guidelines, 2021

Condylomata acuminata of the neovagina in a transgender woman treated with trichloroacetic acid

Sexual health after vaginoplasty: A systematic review

Contact Info

Product

Resources

About